ViaCyte
ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes.
16
Funding Rounds
$328.8m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa** La***** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Li** Po**** | - | - | - |
| Ia* F. Sm*** | - | - | - |
| Pa** J. Ha****** | - | - | - |
| Lu**** Ia******* | - | - | - |
| As*** K. Xa**** | - | - | - |
| Ad** Ko**** | - | - | - |
| Fr** Mi******* | - | - | - |
| Ma** G. Fo***** | - | - | - |
| Sa**** E. Po*** | - | - | - |
| Am** Za**** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa** La***** | - | - |
Funding
Funding series
Funding Series Analysis
The company ViaCyte has raised a total of $197m in funding over 16 rounds.
Key Insights:
- ViaCyte Series D round (extension), June 2021: $45m
- ViaCyte Series D round, May 2020: $27m
- ViaCyte Series D round, November 2018: $80m
- ViaCyte Series C round: $25m
- ViaCyte funding round, May 2006: $20m
- ViaCyte funding round, May 2017: $10m
- ViaCyte Convertible note, September 2018: $10m
- ViaCyte Grant (money), December 2017: $1.4m
- ViaCyte Grant (money), July 2016: $3.9m
- ViaCyte Grant (money), September 2014: $16.6m
- ViaCyte Venture round, August 2014: $20m
- ViaCyte Series C round, August 2014: $5.4m
- ViaCyte Inc. funding round, April 2021: $53.9m
- ViaCyte Inc. funding round, July 2013: $10.6m
ViaCyte Series D round (extension), June 2021
$45m
ViaCyte Series D round, May 2020
$27m
ViaCyte Series D round, November 2018
$80m
ViaCyte Series C round
$25m
ViaCyte funding round, May 2006
$20m
ViaCyte funding round, May 2017
$10m
ViaCyte Convertible note, September 2018
$10m
ViaCyte Grant (money), December 2017
$1.4m
ViaCyte Grant (money), July 2016
$3.9m
ViaCyte Grant (money), September 2014
$16.6m
ViaCyte Venture round, August 2014
$20m
ViaCyte Series C round, August 2014
$5.4m
ViaCyte Inc. funding round, April 2021
$53.9m
ViaCyte Inc. funding round, July 2013
$10.6m
Industries
ViaCyte is active in the following industries: